カルシヌーリン阻害剤誘発性腎繊維症におけるピルーバート脱水素と細胞代謝
Yasuhiro Oda1, Hiroshi Nishi1, Fumie Hamano2
1Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Journal of the American Society of Nephrology : JASN
|August 29, 2025
まとめ
カルシヌーリンの阻害剤は,ピルベート脱水素酶を無効化し,代謝機能障害と細胞衰老を引き起こします. ピルバート脱水素酵素の活性化により,この腎毒性が軽減され,線維症が軽減されます.
科学分野:
- 腎臓科
- 免疫学
- 分子生物学
背景:
- カルシヌーリン阻害剤 (CNIs) は,移植受容者や自己免疫疾患の患者にとって不可欠な免疫抑制剤です.
- 慢性的なCNI使用は腎臓毒性および腎臓線維症につながるが,その根本的なメカニズムは不明である.
研究 の 目的:
- 単細胞解像度を使用して慢性 CNI 腎毒性の初期の細胞および分子変化を調査する.
- CNI誘発性腎繊維症における代謝機能障害の役割を解明する.
主な方法:
- 慢性 CNI 治療中のマウスの腎臓の単核 RNA 配列化 (snRNA-seq).
- CNIに曝露した原始ヒト腎管内皮細胞を用いたin vitro試験.
- マウスモデルにおけるピルーバート脱水素酶活性化剤による薬理学的介入
主要な成果:
- snRNA-seqは近接管細胞損傷,老化,および線維症遺伝子発現の増加を示した.
- CNIは,ピルバート脱水素酶を無効化することで,ヒト腎細胞のミトコンドリア代謝を低下させ,老化を誘導した.
- ピルバ酸脱水素酵素の活性化により,マウスのCNI誘発の代謝機能障害,老化,腎臓線維症が改善された.
結論:
- CNI誘発性腎中毒は,ピルバート脱水素酵素の不活性化と近接管細胞の代謝機能障害を含む.
- 付近管細胞の代謝機能障害は,慢性 CNI 腎中毒性の初期の特徴である.
- CNI誘発性腎臓線維症に対する潜在的な治療戦略を提示しています.
関連する概念動画
01:28Chronic Kidney Disease III: Interprofessional Care
77
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
77
01:29Acute Kidney Injury II: Pathophysiology
72
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
72
01:24Chronic Kidney Disease II: Clinical Manifestations
85
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
85
01:25Chronic Kidney Disease I: Introduction
65
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
65